"The greatest risk of hubris to human health comes in the form of antibiotic-resistant bacteria."

- The World Economic Forum's Global Risks 2013

Learn how Cubist is leading the battle against superbugs and advancing the R&D of new therapies to treat serious and potentially life threatening infections. 

Every day, our experts search for new discoveries and push scientific boundaries in our efforts to deliver powerful medicines for some of the greatest medical challenges.  More 

09/19/2014 - Statement for the record from Cubist Pharmaceuticals: Hearing on 21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development   More 


At Cubist, our culture is our foundation. We share a passion for learning, collaborating, innovating, and most of all, making a difference in people’s lives.